Human beta-defensin-3 promotes wound healing in infected diabetic wounds
FDA in 1997 in the context of pediatric growth hormone deficiency, and the original product was later discontinued for commercial reasons around 2008
And again, as I wrote in The TOT Bible many years ago, there is a reason why you are using Ipamorelin and not any other GHRP on the market: Other GHRPs (GHRP-6, GHRP-2, Hexarelin, etc.), some of which are stronger in their ability to increase growth hormone release than Ipamorelin, have noticeable negative side effects that normally come from increased cortisol and prolactin production
In skincare, AHK-Cu boosts collagen & elastin production, improving skin texture, tone, and flexibility while visibly reducing wrinkles and fine lines
We do not currently expect to commercialize any of our product candidates until after the expiration of Pfizers patent protection
Our latest (V